Published in Circulation on November 28, 2000
PIE II: Pharmacological Intervention in the Elderly II | NCT00123955
Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy | NCT00879060
A Study Of The Usage Of Statins In A Community Heart Failure Population | NCT00795912
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med (2010) 3.42
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
Aldosterone-induced inflammation in the rat heart : role of oxidative stress. Am J Pathol (2002) 2.33
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J (2013) 2.21
T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology (2012) 1.83
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair (2012) 1.65
Mechanisms of disease: hypertrophic cardiomyopathy. Nat Rev Cardiol (2011) 1.55
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag (2008) 1.49
Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure. Circ Heart Fail (2012) 1.39
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging (2013) 1.35
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol (2013) 1.22
Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation (2010) 1.21
Diabetic cardiomyopathy. Clin Sci (Lond) (2009) 1.18
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int (2009) 1.17
Myocardial T1 mapping: techniques and potential applications. Radiographics (2014) 1.09
Exercise intolerance. Heart Fail Clin (2008) 1.09
Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol (2009) 1.06
Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol (2011) 1.05
Extracellular matrix fibrotic markers in heart failure. Heart Fail Rev (2010) 1.05
Integrating the myocardial matrix into heart failure recognition and management. Circ Res (2013) 1.00
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol (2003) 1.00
The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study. Circ Heart Fail (2011) 0.99
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am Heart J (2007) 0.99
Targeting the renin-angiotensin-aldosterone system in heart failure. Nat Rev Cardiol (2013) 0.95
Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch (2008) 0.92
Aldosterone blockade in cardiovascular disease. Heart (2004) 0.92
Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension (2015) 0.90
Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis. Br J Clin Pharmacol (2013) 0.90
Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology. Can J Cardiol (2009) 0.89
Aldosterone receptor antagonists: current perspectives and therapies. Vasc Health Risk Manag (2013) 0.88
Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms. Am J Physiol Heart Circ Physiol (2009) 0.86
Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev (2003) 0.86
Clinical adoption of prognostic biomarkers: the case for heart failure. Prog Cardiovasc Dis (2012) 0.85
Effects of spironolactone on human blood mononuclear cells: mineralocorticoid receptor independent effects on gene expression and late apoptosis induction. Br J Pharmacol (2006) 0.84
Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure. Heart Fail Rev (2005) 0.84
Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner. Am J Pathol (2007) 0.84
Aldosterone and myocardial extracellular matrix expansion in type 2 diabetes mellitus. Am J Cardiol (2013) 0.84
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure. Heart Fail Rev (2010) 0.84
Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly. Heart Fail Rev (2008) 0.83
Exercise intolerance. Cardiol Clin (2011) 0.82
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat Rev Drug Discov (2016) 0.82
Curcumin Suppress Cardiac Fibroblasts Activities by Regulating Proliferation, Migration, and the Extracellular Matrix. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.82
Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease. Int J Cardiol (2015) 0.82
Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo. PLoS One (2012) 0.82
MR relaxometry and perfusion of the myocardium in spontaneously hypertensive rat: correlation with histopathology and effect of anti-hypertensive therapy. Eur Radiol (2013) 0.81
Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice. PLoS One (2012) 0.80
Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials. BMC Med (2015) 0.80
The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure. Heart Fail Rev (2012) 0.80
Valsartan in the treatment of heart attack survivors. Vasc Health Risk Manag (2006) 0.80
Pharmacological treatment of chronic heart failure. Heart Fail Rev (2006) 0.79
Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy. Pacing Clin Electrophysiol (2010) 0.79
Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure. Int J Med Sci (2014) 0.78
Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure. J Cardiovasc Pharmacol Ther (2014) 0.78
Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone. Pflugers Arch (2007) 0.78
The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death. Clin Chem Lab Med (2010) 0.78
Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging. Radiol Clin North Am (2014) 0.77
Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. J Am Heart Assoc (2013) 0.77
TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis. Mol Cell Endocrinol (2016) 0.77
The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists. PLoS One (2015) 0.77
Spironolactone improves endothelial dysfunction in ankylosing spondylitis. Clin Rheumatol (2013) 0.77
Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction. Exp Ther Med (2014) 0.76
Changes in the myocardial interstitium and contribution to the progression of heart failure. Heart Fail Clin (2012) 0.76
Pericryptal myofibroblast growth in rat descending colon induced by low-sodium diets is mediated by aldosterone and not by angiotensin II. J Membr Biol (2005) 0.76
Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance. Heart Fail Rev (2015) 0.76
New drugs for atrial fibrillation. J Interv Card Electrophysiol (2008) 0.76
Aldosterone receptor blockade in the management of heart failure. Heart Fail Rev (2002) 0.75
Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats. Exp Ther Med (2012) 0.75
Rac1 GTPase Regulates 11β Hydroxysteroid Dehydrogenase Type 2 and Fibrotic Remodeling. J Biol Chem (2017) 0.75
Cardiac fibrosis and miR-433. Ann Transl Med (2016) 0.75
The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events. PLoS One (2015) 0.75
Rationale and design of a randomized trial on the impact of aldosterone antagonism on cardiac structure and function in diabetic cardiomyopathy. Cardiovasc Diabetol (2013) 0.75
Circulating Aldosterone Levels and Disease Severity in Pulmonary Arterial Hypertension. J Pulm Respir Med (2015) 0.75
Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. J Obes Weight Loss Ther (2012) 0.75
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study. BMC Cardiovasc Disord (2007) 0.75
Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management. ScientificWorldJournal (2013) 0.75
Circulating Procollagen Type III N-Terminal Peptide and Mortality Risk in African Americans With Heart Failure. J Card Fail (2015) 0.75
Effect of spironolactone on ventricular arrhythmias in patients with left ventricular systolic dysfunction and implantable cardioverter defibrillators. Indian Heart J (2012) 0.75
Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol (2016) 0.75
Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm. Br J Pharmacol (2016) 0.75
A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling. PLoS One (2015) 0.75
Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis. Biomarkers (2015) 0.75
The left ventricle in aortic stenosis--imaging assessment and clinical implications. Cardiovasc Ultrasound (2015) 0.75
Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure. Heart Fail Clin (2014) 0.75
Assessment and impact of diastolic function by echocardiography in elderly patients. J Geriatr Cardiol (2016) 0.75
Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling. Heart Fail Rev (2004) 0.75
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med (1999) 29.32
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav (2004) 5.15
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
Management of heart failure. I. Pharmacologic treatment. JAMA (1994) 4.07
Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia (2012) 3.70
Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav (2004) 3.69
A vital stain for studying membrane dynamics in bacteria: a novel mechanism controlling septation during Bacillus subtilis sporulation. Mol Microbiol (1999) 3.42
"Atypical" depression following childbirth. Br J Psychiatry (1968) 3.32
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res (2003) 3.22
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circulation (1975) 2.77
Sex ratio associated with timing of insemination and length of the follicular phase in planned and unplanned pregnancies during use of natural family planning. Hum Reprod (1998) 2.67
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation (1994) 2.61
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol (2014) 2.50
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol (2006) 2.28
Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation (1977) 2.22
BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ (1992) 2.21
Functional results after extended myotomy for diffuse oesophageal spasm. Br J Surg (2007) 2.20
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial. N Engl J Med (1983) 2.18
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man. N Engl J Med (1971) 2.05
Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res (1971) 2.05
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation (1980) 1.88
Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol (2004) 1.79
Randomized clinical trial of early versus delayed temporary stoma closure after proctectomy. Br J Surg (2008) 1.77
Sudden death in the year following myocardial infarction. Relation to ventricular premature contractions in the late hospitals phase and left ventricular ejection fraction. Am J Med (1977) 1.77
Patient-controlled interscalene analgesia after shoulder surgery: catheter insertion by the posterior approach. Anesth Analg (2005) 1.69
Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood (1992) 1.69
Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine. Cancer Res (1974) 1.68
Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol (1989) 1.61
Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine. J Am Coll Cardiol (1999) 1.57
Use of phentolamine in acute myocardial infarction associated with hypertension and left ventricular failure. Circulation (1973) 1.57
Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol (2001) 1.57
Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol (1999) 1.56
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol (1996) 1.55
Abusing old people. BMJ (1992) 1.53
Digitalis Investigation Group (DIG) trial: a stimulus for further research. Am Heart J (1997) 1.53
Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock. Intensive Care Med (1999) 1.52
Better functional status in American than Canadian patients with heart disease: an effect of medical care? J Am Coll Cardiol (1995) 1.50
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis (2001) 1.48
Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol (1998) 1.48
Scintiphotographic evaluation of patients with suspected left ventricular aneurysm. Circulation (1974) 1.45
Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol (2000) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Thallium-201 for myocardial imaging: appearance of the normal heart. J Nucl Med (1976) 1.43
Evidence for the detrimental role of proteolysis during liver preservation in humans. Gastroenterology (1995) 1.40
A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med (1988) 1.39
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial. Am J Cardiol (1999) 1.39
Multiple intrahepatic stones caused by hemobilia in liver transplant recipients. Surgery (1997) 1.39
[Labour epidural analgesia in Martinique: evaluation of quality and accessibility to epidural analgesia by the patients in level one obstetric clinic]. Ann Fr Anesth Reanim (2004) 1.39
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol (2004) 1.39
Serum lipids and apolipoproteins in liver transplant recipients: a comparative study of cyclosporin A and FK 506. J Lab Clin Med (1994) 1.39
[Original scientific articles, a new start for the Journal de Chirurgie!]. J Chir (Paris) (2007) 1.39
[Bio-banks: changes arising from the new bioethics law]. Rev Epidemiol Sante Publique (2006) 1.39
Laparoscopic versus open incisional hernia repair: a single-institution analysis of hospital resource utilization for 884 consecutive cases. Surg Endosc (2005) 1.37
A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol (1971) 1.37
Risk of recurrent spontaneous abortion for pregnancies discovered in the fifth week of gestation. Lancet (1994) 1.37
Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. J Investig Allergol Clin Immunol (2011) 1.34
Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation (1989) 1.33
Intravenous nitroglycerin in acute myocardial infarction. Circulation (1975) 1.32
Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther (2007) 1.30
Doctor-patient communication in different European health care systems: relevance and performance from the patients' perspective. Patient Educ Couns (2000) 1.29
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29
Unstable angina pectoris: morbidity and mortality in 57 consecutive patients evaluated angiographically. Am J Cardiol (1973) 1.28
Necrotizing pancreatitis: contemporary analysis of 99 consecutive cases. Ann Surg (2001) 1.28
Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod (2003) 1.25
The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins (1980) 1.24
Communication in general practice: differences between European countries. Fam Pract (2003) 1.23
Regional myocardial blood flow in the dog studied with radioactive microspheres. Cardiovasc Res (1971) 1.23
Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci (2000) 1.23
Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circulation (1976) 1.23
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation (1994) 1.21
Evaluating quality of care for patients with heart failure. Circulation (2000) 1.21
Myxoma of the left atrium. Hemodynamic and phonocardiographic consequences of sudden tumor movement. Circulation (1967) 1.21
Coronary hemodynamic effects of increasing ventricular rate in the unanesthetized dog. Circ Res (1968) 1.21
Quantitative analysis of flow microfluorometric data from asynchronous and drug-treated cell populations. Comput Biomed Res (1976) 1.21
Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation (1977) 1.20
Stage-specific effects of sonic hedgehog expression in the epidermis. Dev Biol (1998) 1.19
The 'dop' system around Stellenbosch--results of a farm survey. S Afr Med J (1998) 1.18
In utero ethanol exposure causes mitochondrial dysfunction, which can result in apoptotic cell death in fetal brain: a potential role for 4-hydroxynonenal. Alcohol Clin Exp Res (2001) 1.18
Direct interaction of proliferating cell nuclear antigen with the p125 catalytic subunit of mammalian DNA polymerase delta. J Biol Chem (1999) 1.17
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J (1991) 1.15
Effect of propranolol on regional myocardial blood flow in acute ischaemia. Cardiovasc Res (1970) 1.15
Are all angiotensin-converting enzyme inhibitors interchangeable? J Am Coll Cardiol (2001) 1.14
Muc4/sialomucin complex in the mammary gland and breast cancer. J Mammary Gland Biol Neoplasia (2001) 1.14